Breaking News, Promotions & Moves

Vyome Welcomes Jerry Leonard as New Chief Financial Officer

Leonard is a seasoned public company finance executive with more than 25 years’ experience in areas such as SEC reporting, financial operations, and governance.

Why This Matters: See our coverage of other industry executive team appointments and promotions here.

Vyome, a clinical-stage biopharmaceutical company, named senior financial executive Jerry Leonard its new Chief Financial Officer. Leonard stepped into the role Sept. 1, 2026, succeeding Interim Chief Financial Officer Robert Dickey IV.

At Vyome—which develops differentiated therapies for immuno-inflammatory and rare disease conditions—Leonard will oversee financial operations and reporting. He will also supervise accounting, internal controls, and corporate governance responsibilities related to these tasks.

Vyome Mission and Outlook

Vyome seeks to build the world’s premier platform spanning the United States–India innovation corridor.

Among Leonard’s 25-plus years’ experience in financial management, leadership, and corporate strategy, he is the founder and CEO of ClearBridgeCFO. He was Senior Vice President, Chief Financial Officer, and Secretary of VSee Health following its 2024 business combination. Prior to that, Leonard was Chief Financial Officer of iDoc Virtual Telehealth Solutions and VSee Lab.

Venkat Nelabhotla, Vyome CEO

Leonard’s other work experience includes more than a decade as Vice President of Finance in Voya Financial’s asset management business. He began his career in public accounting with stints at Arthur Andersen and PricewaterhouseCoopers.

Chief Financial Officer Speaks

“Vyome has built a disciplined financial foundation as it continues to advance its development pipeline,” Leonard said. “I look forward to … further strengthen[ing] the company’s financial operations, reporting, controls, and governance.”

Vyome CEO Venkat Nelabhotla touted Leonard’s combination of public company leadership and experience in reporting, financial operations, and governance.

“We believe [this] is particularly relevant to Vyome as we continue to build our organization,” Nelabhotla said. “[Leonard’s] experience across emerging public companies as well as large global organizations will be valuable in strengthening our financial processes.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters